Pfizer Accused of Largest Tax Dodging Scheme in Pharmaceutical Industry History
by Carolyn Hendler, JD
Pfizer, Inc. has been accused of engaging in the largest tax dodging scheme in pharmaceutical history. After a four-year investigation into pharmaceutical ...
Pfizer Settles Anti-Kickback Violation Claims for Nearly $60 Million
by Carolyn Hendler, JD
Pfizer, Inc., on behalf of its wholly owned subsidiary Biohaven Pharmaceuticals, Inc. has paid almost $60 million dollars to settle ...
FDA Official Leaves Agency Through the “Revolving Door” and Returns to Pfizer
by Rishma Parpia
On Feb. 24,2025, Pfizer, Inc. announced that FDA official Patrizia Cavazzoni, MD will rejoin the pharmaceutical company, which makes and ...
Pfizer’s Corporate Partnership With American Cancer Society Raises Conflict of Interest Questions
by Rishma Parpia
Pfizer, Inc. reported that it has been named the American Cancer Society’s (ACS) “2024 Corporate Partner of the Year.” The ...
Meta’s Zuckerberg Acknowledges Censoring Information About COVID Shots
by Natasha Hobley
A recent press video announcement and press release issued on Jan. 7, 2025 by Mark Zuckerberg, co-founder of Facebook and ...
Supreme Court Reverses Preliminary Injunction Against Government for Coercing Social Media Firms to Censor Speech
by Carolyn Hendler, JD
The states of Missouri and Louisiana, together with three doctors, a health care advocate and a news website, sued federal ...
Australian Judge in COVID Shot Case Failed to Disclose Ties to Pfizer
by Rishma Parpia
During the COVID-19 pandemic, the Government of Australia implemented very strict lockdown measures and public health policies, including mask and ...
“X” Owner Elon Musk to Pay Legal Bills of Canadian Pediatrician in Libel Lawsuit Over Free Speech Censorship
by Rishma Parpia
Canadian pediatrician Kulvinder Kauer Gill, MD has been given a helping hand by entrepreneur Elon Musk, owner of “X” (formerly ...
Harvard Medical Professor Fired for Opposing COVID Lockdowns and Vaccine Mandates
by Amber Baker
Epidemiologist, biostatistician, and professor of medicine at Harvard Medical School Martin Kulldorff, MD announced on social media last week that ...
In this section
Latest
Popular
Comments
Latest
FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants
by Amber Baker and Barbara Loe Fisher
Popular
Comments
Allie on FDA Licenses Moderna’s mNEXSPIKE COVID Shot for Individuals at High Risk for Severe COVID Disease
CAWS on Oral Rabies Vaccine Deployed by Air to Vaccinate Wildlife in Vermont
Nicki Cooke on FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants
B.C. on FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants
CATRYNA WHITE on FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants
